President of the National Research Center (NRC) Mohamed Mahmoud Hashem has said that he sees positive indicators for using the Japanese drug Avigan to cure people infected with the novel coronavirus (COVID-19).
In an official statement released on Tuesday, Hashem added that the NRC is working on studying the effectiveness and safety of more than 70 drugs, including Avigan, in the treatment of coronavirus patients.
He went on to say that the NRC administration assigned a number of researchers to develop vaccines or drugs against coronavirus.
Hashem asserted that those researchers are funded by the NRC, denying circulated reports about receiving support or finance from any domestic or international entity.
Short link: